0
ARTICLE |

Leads from the MMWR FREE

JAMA. 1985;253(18):2630-2638. doi:10.1001/jama.1985.03350420032006
Text Size: A A A
Published online

REFERENCES

Cochi SL, Broome CV, Hightower AW:  Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine: A cost-effectiveness model of strategy assessment . JAMA 1985;;253:521-529.
Istre GR, Conner JS, Broome CV, Hightower A, Hopkins RS:  Risk factors for primary invasive Haemophilus influenzae disease. Increased risk from day care attendance and school-aged household members . J Pediatr 1985;;106:190-195.
Redmond SR, Pichichero ME:  Haemophilus influenzae type b disease. An epidemiologic study with special reference to day-care centers . JAMA 1984;;252:2581-2584.
CDC:  Prevention of secondary cases of Haemophilus influenzae type b disease . MMWR 1982;;31:672-680.
Murphy TV, Breedlove JA, Fritz EH, Sebestyen DM, Hansen EJ:  County-wide surveillance of invasive Haemophilus infections: Risk of associated cases in child care programs (CCPs) . Twenty-third Interscience Conference on Antimicrobial Agents and Chemotherapy 1983 ;229 (abstract #788).
Fleming D, Leibenhaut M, Albanes D, et al:  Haemophilus influenzae b (Hib) disease—secondary spread in day care . Twenty-fourth International Conference on Antimicrobial Agents and Chemotherapy 1984 ;261 (abstract #967).
Smith DH, Peter G, Ingram DL, Harding AL, Anderson P:  Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae, type b . Pediatrics 1973;;52:637-644.
Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK:  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies . Pediatr Res 1973;;7:103-110.
Peltola H, Käyhty H, Virtanen M, Mäkelä PH:  Prevention of Haemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine . N Engl J Med 1984;;310:1561-1566.
Käyhty H, Karanko V, Peltola H, Mäkelä PH:  Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: No evidence of immunological tolerance or memory . Pediatrics 1984;;74:857-865.
Robbins JB, Schneerson R, Parke JC Jr:  A review of the efficacy trials with Haemophilus influenzae type b polysaccharide vaccines , in Sell SH, Wright PF (eds): Haemophilus influenzae . New York, Elsevier Science Publishing Co, 1982;, pp 255-263.
Käyhty H, Peltola H, Karanko V, Mäkelä PH:  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b . J Infect Dis 1983;;147:1100.
Anderson P:  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b, letter . J Infect Dis 1984;;149:1034-1035.
Ward J, Smith AL:  Haemophilus influenzae bacteremia in children with sickle cell disease . J Pediatr 1976;;88:261-263.
Siber GR:  Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae: Their occurrence and course in children with cancer . Am J Dis Child 1980;;134:668-672.
Parke JC Jr, Schneerson R, Robbins JB, and Schlesselman JJ:  Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976) . J Infect Dis 1977;;136:S51-S56.
Lepow ML, Peter G, Glode MP, et al:  Response of infants to Haemophilus influenzae type b polysaccharide and diphtheriatetanus-pertussis vaccines in combination . J Infect Dis 1984;; 149:950-955.
Glass RI, Craven RB, Bregman DJ, et al:  Injuries from the Wichita Falls tornado: Implication for prevention . Science 1980;;207:734-738.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Cochi SL, Broome CV, Hightower AW:  Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine: A cost-effectiveness model of strategy assessment . JAMA 1985;;253:521-529.
Istre GR, Conner JS, Broome CV, Hightower A, Hopkins RS:  Risk factors for primary invasive Haemophilus influenzae disease. Increased risk from day care attendance and school-aged household members . J Pediatr 1985;;106:190-195.
Redmond SR, Pichichero ME:  Haemophilus influenzae type b disease. An epidemiologic study with special reference to day-care centers . JAMA 1984;;252:2581-2584.
CDC:  Prevention of secondary cases of Haemophilus influenzae type b disease . MMWR 1982;;31:672-680.
Murphy TV, Breedlove JA, Fritz EH, Sebestyen DM, Hansen EJ:  County-wide surveillance of invasive Haemophilus infections: Risk of associated cases in child care programs (CCPs) . Twenty-third Interscience Conference on Antimicrobial Agents and Chemotherapy 1983 ;229 (abstract #788).
Fleming D, Leibenhaut M, Albanes D, et al:  Haemophilus influenzae b (Hib) disease—secondary spread in day care . Twenty-fourth International Conference on Antimicrobial Agents and Chemotherapy 1984 ;261 (abstract #967).
Smith DH, Peter G, Ingram DL, Harding AL, Anderson P:  Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae, type b . Pediatrics 1973;;52:637-644.
Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK:  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies . Pediatr Res 1973;;7:103-110.
Peltola H, Käyhty H, Virtanen M, Mäkelä PH:  Prevention of Haemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine . N Engl J Med 1984;;310:1561-1566.
Käyhty H, Karanko V, Peltola H, Mäkelä PH:  Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: No evidence of immunological tolerance or memory . Pediatrics 1984;;74:857-865.
Robbins JB, Schneerson R, Parke JC Jr:  A review of the efficacy trials with Haemophilus influenzae type b polysaccharide vaccines , in Sell SH, Wright PF (eds): Haemophilus influenzae . New York, Elsevier Science Publishing Co, 1982;, pp 255-263.
Käyhty H, Peltola H, Karanko V, Mäkelä PH:  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b . J Infect Dis 1983;;147:1100.
Anderson P:  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b, letter . J Infect Dis 1984;;149:1034-1035.
Ward J, Smith AL:  Haemophilus influenzae bacteremia in children with sickle cell disease . J Pediatr 1976;;88:261-263.
Siber GR:  Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae: Their occurrence and course in children with cancer . Am J Dis Child 1980;;134:668-672.
Parke JC Jr, Schneerson R, Robbins JB, and Schlesselman JJ:  Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976) . J Infect Dis 1977;;136:S51-S56.
Lepow ML, Peter G, Glode MP, et al:  Response of infants to Haemophilus influenzae type b polysaccharide and diphtheriatetanus-pertussis vaccines in combination . J Infect Dis 1984;; 149:950-955.
Glass RI, Craven RB, Bregman DJ, et al:  Injuries from the Wichita Falls tornado: Implication for prevention . Science 1980;;207:734-738.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.